News Releases

Otsuka Pharmaceutical Co., Ltd.

May 15, 2017

Corporate

Otsuka Pharmaceutical Announces Construction of New
Pharmaceutical Manufacturing Facility, Tokushima Mima Factory

Otsuka Pharmaceutical Co., Ltd. (Head Office: Tokyo, Japan; President: Tatsuo Higuchi) has announced plans to construct a new pharmaceutical manufacturing facility in Mima City, strategically located in the western part of Tokushima Prefecture. Construction of the new Tokushima Mima Factory is scheduled to begin in May 2017.

       Architectural rendering

Otsuka Pharmaceutical currently manufactures pharmaceuticals at five factories*1 in Japan. The stable supply of high quality pharmaceuticals and pharmaceutical ingredients is necessary as the company continues to pursue global expansion of its pharmaceutical business.
Constructed to ensure a stable supply of quality pharmaceutical products in accordance to international GMP guidelines*2, the new Tokushima Mima Factory is scheduled to start manufacturing operations in 2020.

The Miwa City area is known for its abundant pure water and natural beauty. In addition to current locations in the eastern (Tokushima Factory, Tokushima Second Factory), southern (Tokushima Wajiki Factory) and northern (Tokushima Itano Factory) areas of Tokushima Prefecture, the construction of the Tokushima Miwa Factory expands Otsuka Pharmaceutical’s presence to western Tokushima, enabling the company to contribute to the renewed vitality of its home prefecture as a whole.

  • *1 Tokushima Factory; Second Tokushima Factory; Tokushima Wajiki Factory; Tokushima Itano Factory; Saga Factory
  • *2 GMP:Good Manufacturing Practices are a system of guidelines to ensure consistent production of pharmaceutical products according to established quality standards, covering all aspects of production from procurement of materials through shipment of finished products including design and construction of premises and installation of equipment to minimize human error in the manufacturing process.

Information in this news release was current as of the original release date.